UCL Cancer Institute (UCL CI) is a state-of-the-art institute to consolidate cancer research at UCL and promote links with our partner teaching hospitals, in order to support excellence in basic and translational studies. The Institute draws together talented scientists who are working together to translate research discoveries into developing kinder, more effective therapies for cancer patients. It is a Cancer Research UK and Experimental Cancer Medicine Centre, and contains approximately 580 staff, icluding 120 PhD and MD (Res) students and 40 MSc students.
We are seeking to appoint a pathologist as a Clinical Research Fellow in prostate cancer
histopathology.
The STAMPEDE trial ( ) was the first multi-arm multi-stage platform trial to open (in 2004) and to date has contributed to several large-scale changes in the management of patients with advanced prostate cancer.
Over the past few years we have used molecular tests for bioma...